Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.4 USD | -0.72% | +2.65% | +1.06% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.06% | 527M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.28% | 33.03B | |
+55.32% | 24.68B | |
-16.48% | 15.12B | |
-9.07% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals : Roth Capital Adjusts Price Target on KalVista Pharmaceuticals to $55 From $30, Maintains Buy Rating